Lysophosphatidic Acid Inhibits CC Chemokine Ligand 5/RANTES Production by Blocking IRF-1–Mediated Gene Transcription in Human Bronchial Epithelial Cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Immunology

• Publication date

  2010-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1000904PMID 20861350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human rhinovirus-induced epithelial production of CXCL10 is dependent upon IFN regulatory factor-1.

  2010cited by this paper
• Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma

  2009cited by this paper
• Lysophosphatidic Acid Enhances Pulmonary Epithelial Barrier Integrity and Protects Endotoxin-induced Epithelial Barrier Disruption and Lung Injury*

  2009cited by this paper
• Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

  2009cited by this paper
• Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.

  2008cited by this paper
• The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

  2008cited by this paper
• Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular Injury Responses but Not Blood Pressure

  2008cited by this paper
• LPA1 receptor activation promotes renal interstitial fibrosis.

  2007cited by this paper
• Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge

  2007cited by this paper
• Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

  2007cited by this paper
• Lysophosphatidic Acid Induces Interleukin-13 (IL-13) Receptor α2 Expression and Inhibits IL-13 Signaling in Primary Human Bronchial Epithelial Cells*

  2007cited by this paper
• TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells

  2006cited by this paper
• C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1*

  2006cited by this paper
• TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells.

  2006cited by this paper
• Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

  2005cited by this paper
• G-protein-coupled receptor agonists differentially regulate basal or tumor necrosis factor-alpha-stimulated activation of interleukin-6 and RANTES in human airway smooth muscle cells.

  2005cited by this paper
• Sphingosine 1-phosphate inhibits migration and RANTES production in human bronchial smooth muscle cells.

  2005cited by this paper
• C5a negatively regulates toll-like receptor 4-induced immune responses.

  2005cited by this paper
• G-Protein-coupled receptor agonists differentially regulate basal or tumor necrosis factor-α-stimulated activation of interleukin-6 and RANTES in human airway smooth muscle cells

  2005cited by this paper
• A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity

  2004cited by this paper
• Sphingosine‐1‐phosphate stimulates contraction of human airway smooth muscle cells

  2003cited by this paper
• Gα12 and Gα13 as key regulatory mediator in signal transduction

  2003cited by this paper
• Galpha12 and Galpha13 as key regulatory mediator in signal transduction.

  2003cited by this paper
• Differential Requirement of Gα12, Gα13, Gαq, and Gβγ for Endothelin-1-Induced c-Jun NH2-Terminal Kinase and Extracellular Signal-Regulated Kinase Activation

  2003cited by this paper
• Differential requirement of G alpha12, G alpha13, G alphaq, and G beta gamma for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation.

  2003cited by this paper
• Molecular basis for lysophosphatidic acid receptor antagonist selectivity.

  2002cited by this paper
• IL-17 Selectively Down-Regulates TNF-α-Induced RANTES Gene Expression in Human Colonic Subepithelial Myofibroblasts1

  2002cited by this paper
• Regulation of interleukin-12 production by G-protein-coupled receptors.

  2001influential reference
• Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.

  2001cited by this paper
• CCL chemokines and asthma.

  2000cited by this paper
• Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.

  2000cited by this paper
• Selective Suppression of IL-12 Production by Chemoattractants

  2000influential reference
• Interleukin-1β induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors☆

  2000cited by this paper
• Regulation of RANTES Chemokine Gene Expression Requires Cooperativity Between NF-κB and IFN-Regulatory Factor Transcription Factors1

  2000cited by this paper
• Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.

  1999cited by this paper
• Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.

  1999cited by this paper
• Induction of transcription factor interferon regulatory factor‐1 by interferon‐γ (IFNγ) and tumor necrosis factor‐α (TNFα) in FRTL‐5 cells

  1999cited by this paper
• Chemokines and allergic disease.

  1999cited by this paper
• Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects.

  1997cited by this paper
• Convergence of TNFα and IFNγ signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/κB promoter element

  1997cited by this paper
• Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element.

  1997cited by this paper
• T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma.

  1995cited by this paper
• Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.

  1995cited by this paper
• Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.

  1995cited by this paper
• Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression.

  1994cited by this paper
• Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8

  1993cited by this paper
• RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes

  1992cited by this paper
• CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

  1990cited by this paper
• Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

  1990cited by this paper
• Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

  1989cited by this paper

• EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy

  2025cites this paper
• Cancer mutation profiles predict ICIs efficacy in patients with non-small cell lung cancer

  2022cites this paper
• Antitumour immunity regulated by aberrant ERBB family signalling

  2021cites this paper
• Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases

  2020cites this paper
• Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer

  2020cites this paper
• Function of secreted phospholipase A2 group-X in asthma and allergic disease.

  2019cites this paper
• CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.

  2018cites this paper
• Phosphoinositide 3‐Kinase in Asthma: Novel Roles and Therapeutic Approaches

  2017cites this paper
• Role of Th22 and IL-22 in pathogenesis of allergic airway diseases: Pro-inflammatory or anti-inflammatory effect?

  2017cites this paper
• CREB regulates TNF-α-induced GM-CSF secretion via p38 MAPK in human lung fibroblasts.

  2016cites this paper
• Sphingosine‐1‐phosphate inhibits IL‐1‐induced expression of C‐C motif ligand 5 via c‐Fos‐dependent suppression of IFN‐β amplification loop

  2015cites this paper
• Egg yolks inhibit activation of NF-κB and expression of its target genes in adipocytes after partial delipidation.

  2015cites this paper
• The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model

  2015cites this paper
• Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.

  2015cites this paper
• Expression of Airway Remodeling Proteins in Mast Cell Activated by TGF-β Released in OVA-Induced Allergic Responses and Their Inhibition by Low-Dose Irradiation or 8-oxo-dG

  2014cites this paper
• Intra and extracellular functions of sphingosine-1-phosphate in sterile inflammation

  2013cites this paper
• Lysophosphatidic Acid Aberrancies and Hepatocellular Carcinoma: Studies in the MDR2 Gene Knockout Mouse

  2013cites this paper
• Sphingosine Kinase 1 Regulates Tumor Necrosis Factor-mediated RANTES Induction through p38 Mitogen-activated Protein Kinase but Independently of Nuclear Factor κB Activation*

  2013cites this paper
• Autotaxin and lysophosphatidic acid signalling in lung pathophysiology

  2013cites this paper
• Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

  2012cites this paper
• A database of annotated promoters of genes associated with common respiratory and related diseases.

  2012cites this paper
• Lpa2 Is a Negative Regulator of Both Dendritic Cell Activation and Murine Models of Allergic Lung Inflammation

  2012cites this paper
• An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing

  2012cites this paper
• Bioactive Phospholipid Mediators of Inflammation

  2012cites this paper
• Interferon regulatory factors 1 and 4 in T cell mediated immune modulation

  2011cites this paper
• Extracellular acidification induces connective tissue growth factor production through proton-sensing receptor OGR1 in human airway smooth muscle cells.

  2011cites this paper
• Vaccine Immunity to Coccidioidomycosis Occurs by Early Activation of Three Signal Pathways of T Helper Cell Response (Th1, Th2, and Th17)

  2011cites this paper
• Expression analysis of asthma candidate genes during human and murine lung development

  2011cites this paper